BIOTECH LATE GROWTH STAGE (PRIVATE POST-B)

Designed exclusively for Biotech in late growth stage
BOOK TICKETS

Hosted by:
Merck Purple Logo

10:30 Enterome

 


10:45 Antev 300x

 


11:00 Acousia Therapeutics Logo

 


11:15

Panel

HOSTED BY:

Merck Purple Logo


11:45 Leon-nanodrugs

12:00 MetrioPharm Logo

12:15 FREE

12:30 AB2 Bio

 


12:45 ANeuroTech Logo

 


13:00 Alentis logo

 


13:15 Medherant Logo

 


13:30

Nuclera Logo

 


13:45 pheon therapeutics

 


14:00 STORM Therapeutics

 


14:15 Prokarium-1

 


14:30  

14:45

PANEL: Cashing Out on Good Data: Planning for a Successful Liquidity Event

Weather you’re seeking an IPO or considering M&A, liquidity events come with both benefits and challenges. In this session, industry experts will dive.

Gain insights into the essential steps and strategies to effectively plan and execute a liquidity event based on valuable data, early-stage planning, assessing readiness, and building a strong management team. Learn how to maximize valuation, negotiate deals, and ensure a smooth transition for all stakeholders involved. 

  • Exploring the motivations and benefits of liquidity events for companies, founders, and investors
  • Importance of early-stage planning and setting clear goals
  • The role of an experienced and capable management team in driving a successful liquidity event
  • Due diligence preparation and managing potential risks and challenges 

Maximilian Moser, Associate, EQT Life Sciences  
Edouard Guillet, Managing Partner, IPF Partners  

Maximilian Moser Associate EQT Life Sciences  Edouard Guillet, Managing Partner, IPF Partners

 


15:00  

15:45

 


16:00  

16:15  

16:30  

16:45  

17:00  

17:15

Close of Investival Showcase


18:30

Lifestars Logo

Awards & Gala Dinner
- Separate ticket required
- Find out more

DOWNLOAD BROCHURE